Tesamorelin
A 44-residue growth hormone-releasing hormone analogue with an N-terminal trans-3-hexenoyl modification.
Products are offered exclusively for lawful laboratory research by qualified personnel. Not for human or veterinary use. Not intended for diagnosis, treatment, cure, prevention, mitigation, clinical use, food, drug, cosmetic, household, or consumer use.
Product Description
Tesamorelin is a synthetic analogue of human growth hormone-releasing hormone, based on the GHRH(1–44) peptide sequence. It contains an N-terminal trans-3-hexenoyl group and a C-terminal amide. Tesamorelin is studied as a growth hormone-releasing hormone receptor (GHRHR) agonist in receptor and endocrine-signaling research.
Property Information
Reference chemistry for the stated structure; added counterions, hydration, and lot-specific analytical results are documented separately.
| Property | Information |
|---|---|
| Chemical identity | Tesamorelin |
| CAS number | 218949-48-5 |
| Chain length | 44 amino acids |
| Sequence / structure | GHRH(1–44) analogue; N-terminal trans-3-hexenoyl group; C-terminal amide |
| Molecular formula | C221H366N72O67S |
| Molecular weight | 5135.8 g/mol |
| Purity | Lot-specific analytical results available upon request |
| Documentation | Available upon request |
Research References
Quality Assurance & Analytical Documentation
MP Research maintains analytical documentation for its research materials, including available third-party testing and lot-specific quality records.
Certificates of Analysis are maintained as part of our quality assurance program and are available upon request for the applicable product and lot.
For documentation requests, please contact MP Research with the product name and lot number.
All materials are intended strictly for legitimate laboratory research and are not intended for human or veterinary use.




